Nutex Health annual stock-based compensation
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Nutex Health Stock-Based Compensation Growth & History (NUTX)
Nutex Health's stock-based compensation was $107.8M for fiscal 2025.
View full Nutex Health company overviewNutex Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $107.8M | $107.9M | — |
| 2024 | 2024-12-31 | −$129,743 | −$3.0M | — |
| 2023 | 2023-12-31 | $2.8M | $2.6M | +1395.93% |
| 2022 | 2022-12-31 | $189,581 | −$3.8M | −95.29% |
| 2021 | 2021-12-31 | $4.0M | $1.5M | +56.59% |
| 2020 | 2020-12-31 | $2.6M | $2.1M | +471.42% |
| 2019 | 2019-12-31 | $450,054 | $294,168 | +188.71% |
| 2018 | 2018-12-31 | $155,886 | −$768,440 | −83.14% |
| 2017 | 2017-12-31 | $924,326 | $922,826 | +61521.73% |
| 2016 | 2016-12-31 | $1,500 | — | — |
Nutex Health quarterly stock-based compensation
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q3.21
Q1.22
Q3.22
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.9M | −$66.1M | −95.82% |
| Q1 2026 | 2026-03-31 | −$3.9M | −$19.9M | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $22.9M | — | — |
| Q2 2025 | 2025-06-30 | $69.0M | — | — |
| Q1 2025 | 2025-03-31 | $15.9M | — | — |
| Q3 2022 | 2022-09-30 | $81,249 | $81,249 | — |
| Q1 2022 | 2022-03-31 | $14.2M | $10.3M | +268.50% |
| Q3 2021 | 2021-09-30 | $0 | −$304,999 | — |
| Q1 2021 | 2021-03-31 | $3.9M | $3.0M | +353.90% |
| Q4 2020 | 2020-12-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $304,999 | $137,146 | +81.71% |
| Q2 2020 | 2020-06-30 | $1.4M | $914,688 | +181.77% |
| Q1 2020 | 2020-03-31 | $848,778 | $810,068 | +2092.66% |
| Q3 2019 | 2019-09-30 | $167,853 | $167,853 | — |
| Q2 2019 | 2019-06-30 | $503,224 | $414,424 | +466.69% |
| Q1 2019 | 2019-03-31 | $38,710 | $38,710 | — |
| Q4 2018 | 2018-12-31 | $67,086 | — | — |
| Q3 2018 | 2018-09-30 | $0 | −$199,500 | — |
| Q2 2018 | 2018-06-30 | $88,800 | −$649,725 | −87.98% |
| Q1 2018 | 2018-03-31 | $0 | −$800 | — |
| Q3 2017 | 2017-09-30 | $199,500 | — | — |
| Q2 2017 | 2017-06-30 | $738,525 | — | — |
| Q1 2017 | 2017-03-31 | $800 | — | — |
Nutex Health stock-based compensation trends
Over the last five fiscal years, Nutex Health's stock-based compensation increased from $2.6M to $107.8M, a change of $105.2M. The latest reported quarter, Q2 2026, shows $2.9M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nutex Health source filings ↗